July 26, 2019

This morning, the House Committee on Oversight and Reform held a hearing on the impact of skyrocketing prescription drug prices on patients. Several witnesses testified about how they were personally harmed by rising costs. In some cases they had to ration their medici...

July 24, 2019

Prescription drug costs are continuing to rise, but biosimilar medicines offer great promise for patients who need more affordable medicines. Biosimilars are lower-priced versions of brand medicines used to treat long-lasting and life-threatening diseases. Unfortunatel...

July 23, 2019

Just last month, the drug company AbbVie announced that it was going to acquire Allergan, the drug company that makes Botox, for $63 billion in one of the largest mergers in the healthcare industry. This megamerger is a bad idea for consumers, competition, and affordab...

July 22, 2019

On Friday, July 19th, Judge Richard Leon of the District Court for the District of Columbia heard oral arguments from supporters and critics of the CVS-Aetna merger. The $69 billion merger of the pharmacy and pharmacy benefit manager (PBM) CVS and the health insurance...

July 18, 2019

The Trump administration's efforts to lower prescription drug prices are in trouble. Just last week, the administration abruptly withdrew its proposed rule to eliminate the safe harbor for most PBM rebates. And a judge ruled against the administration's requiring drug...

July 18, 2019

In a victory for consumers, pharmacists, and advocates for lower drug costs, Connecticut Governor Ned Lamont signed into a law a bill that would better regulate pharmacy benefit managers (PBMs) and combat their misbehavior.

HB 7363 was approved by both the House and Sen...

July 11, 2019

This morning the Trump administration abandoned its proposed rebate rule to eliminate safe harbor protection for most Medicare rebates acquired by pharmacy benefit managers (PBMs) and to require that those rebates be passed on to consumers, lowering prescription drug c...

July 9, 2019

Prescription drug prices are far too high, and many Americans are being forced to choose between paying for their medicines and other basic necessities such as rent and housing. One of the main causes of high prices are the anticompetitive actions taken by drug compani...

July 9, 2019

The 4th of July is over and Congress is back in session. One of the most important issues for policymakers, health care experts, and ordinary Americans is the rising cost of prescription drugs. The New York Times editorial board just said that "nothing typifies the fai...

July 2, 2019

In the first six months of 2019, prescription drug costs are rising rapidly, despite promises from legislators and the Trump administration to reduce prices, and underscoring how important it is to take action so consumers can access their medicines.

This year over 3,40...

Please reload

Featured Posts